Levels of Matrix-Degrading Enzymes and Lubricin in Patients With Degenerative Joint Disease Requiring Arthroplasty
Christopher Wanderling(University of Rochester), William Hopkinson(Loyola University Medical Center), Stephen Statz(Loyola University Chicago), Nil Güler(Loyola University Medical Center), Debra Hoppensteadt(Loyola University Medical Center), D. Schmitt(Loyola University Medical Center), Elissa S. Davis(Loyola University Medical Center), Jeffrey Liles(Loyola University Chicago), Jawed Fareed(Loyola University Medical Center)
Cited by 9
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Nailfold Capillary Abnormalities in Primary Open-Angle Glaucoma: A Multisite Study
|Investigative Ophthalmology & Visual Science|2015|38
Recent Advances in Surgical Simulation For Resident Education
|Current Urology Reports|2023|30
Increased Level of Thrombotic Biomarkers in Patients with Atrial Fibrillation Despite Traditional and New Anticoagulant Therapy
|Clinical and Applied Thrombosis/Hemostasis|2016|19
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty
|Clinical and Applied Thrombosis/Hemostasis|2017|19